1. Volume 49, Issue 5, Pages 867-870 (November 2008)
Incidental reduction in the size of liver hemangioma following use of VEGF inhibitor bevacizumab 
Dipti Mahajan, Charles Miller, Kenzo Hirose, Arthur McCullough, Lisa Yerian 
Journal of Hepatology 
Volume 49, Issue 5, Pages (November 2008)
DOI: /j.jhep
Copyright © 2008 European Association for the Study of the Liver Terms and Conditions

2. Fig. 1
CT Scan showing pre-treatment dominant lesion (3.6×2.8cm) within segment VI of the liver, suspicious for metastasis (dotted line and arrow).
Journal of Hepatology  , DOI: ( /j.jhep )
Copyright © 2008 European Association for the Study of the Liver Terms and Conditions

3. Fig. 2
Histology of the sigmoid colon mass reveals a moderately differentiated invasive adenocarcinoma. (H&E 20×).
Journal of Hepatology  , DOI: ( /j.jhep )
Copyright © 2008 European Association for the Study of the Liver Terms and Conditions

4. Fig. 3
Post-bevacizumab CT scan showing a reduction in the size of the dominant lesion with blurring of borders (dotted line and arrow).
Journal of Hepatology  , DOI: ( /j.jhep )
Copyright © 2008 European Association for the Study of the Liver Terms and Conditions

5. Fig. 4
Histology of the liver lesions reveal hemangioma with strong and diffuse staining for VEGF (inset) and VEGFr2 (H&E 20×, H&E 40×).
Journal of Hepatology  , DOI: ( /j.jhep )
Copyright © 2008 European Association for the Study of the Liver Terms and Conditions